Table 2.

Efficacy summary

IWG-MRT-ECNM response*, n (%)Overall population (N = 10)
ORR (CR + PR +CI) 0 (0) 
Stable disease 8 (80) 
Progressive disease 1 (10) 
Not evaluable 1 (10) 
IWG-MRT-ECNM response*, n (%)Overall population (N = 10)
ORR (CR + PR +CI) 0 (0) 
Stable disease 8 (80) 
Progressive disease 1 (10) 
Not evaluable 1 (10) 

For the full listing and definitions of response criteria, please see the IWG-MRT-ECNM consensus guidelines.29 

CI, clinical improvement

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal